GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem"

Chairman of the GenoSpace Board of Directors, Joseph Boystak, added that "GenoSpace has tremendous commercial potential, including recurring revenue streams, by its offering customers and constituents high value-added products and services. This is the first company to create an information ecosystem that links at the same time diverse users in ways that can benefit everyone involved. GenoSpace offers the solution for 21st-century genomic medicine."

As early stage customers, GenoSpace is working with disease foundations, pharmaceutical companies, and contract innovation organizations that recruit patients to clinical trials, and hospital systems and service providers that are seeking to connect with each other and looking to solve the problem of clinical and genomic data integration and management. For these and other customers, GenoSpace research addresses their fundamental needs in ways that open up new opportunities.

GenoSpace's CTO, Mick Correll, underscored the distinctive value proposition represented in the company's offering, "Our cloud-based innovation is secure, robust, and infinitely scalable, and the portals we've developed are aimed at solving problems people have today, during being adaptable to the needs of genomic medicine tomorrow. Even in our early days, this unequalled mix of attributes has positioned us so then in the marketplace."